News Sentiment

2256 sentiment intelligence

Abbisko Cayman Limited news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report RSS feed
Weighted score 50 Balanced news tone 4 relevant articles
Exchange HKG Hong Kong
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 10.10 Week of 17 Jul 2026
Weighted tone 50/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Deals and strategy

72/100 classification confidence.

Company focus 4

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend inactive

-7.9% over one week, +11.8% over four weeks, trend inactive, and materially above fair value.

Latest direct headline Neutral

Allianz SE has acquired an additional 599,000 ordinary shares of Abbisko Therapeutics Co., Ltd. (HKEX: 2256), valued at approximately HK$6.8354 million.

Market Reaction

Price moving ahead of tone

55/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Deals and strategy 72/100 classification
One-week reaction -7.9% Price reacting lower
Trend fit Trend inactive 11.8% over four weeks
Fair value 36.8% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 0
Neutral 4
Negative 0

Relevance

Why the article matched

Direct first
Direct company coverage 4
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
富途牛牛 1
thestandard.com.hk 1
Reuters 1
TipRanks 1

Event Lens

What the news is about

Classified themes
Deals and strategy 3
Market update 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-4 of 4